Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions and methods for inhibiting pathogenic growth

a technology of pathogenic growth and composition, applied in the direction of antibacterial agents, biocide, bacteria material medical ingredients, etc., can solve the problems of inability to prevent communicability, diarrhea can be fatal, and the effect of affecting the survival rate of patients

Inactive Publication Date: 2005-11-03
NUTRITION PHYSIOLOGY
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a method for treating or preventing intestinal pathogenic infections in ruminants by administering a composition containing a therapeutically effective amount of a lactic acid producing bacterium. The bacterium reduces the quantity of pathogens in the intestine of the ruminant, thereby reducing the likelihood of contaminated food products resulting from treated animals. The invention exploits the natural competition of certain microorganisms with the pathogens, using them to inhibit their growth. The microorganisms out-grow and out-populate the pathogens by using available nutrients and attachment spaces, thereby overwhelming them and preventing them from becoming established in the GIT. The invention also includes a method of treating or preventing an intestinal pathogenic infection in a ruminant by administering a composition containing a therapeutically effective amount of a lactic acid producing bacterium. The bacterium reduces the quantity of pathogens in the intestine of the ruminant, thereby reducing the likelihood of contaminated food products resulting from treated animals. The invention identifies specific strains of bacteria that can be used for this purpose."

Problems solved by technology

Ingestion of pathogens, especially bacterial pathogens, but including viruses and other disease causing microorganisms, is a common problem in most animals.
For animals that are immunosuppressed or malnourished, even just the effects of diarrhea can be fatal.
Pathogens are often transferred between animals where poor hygiene conditions exist, and sometimes communicability cannot be prevented even when great care is taken.
The most common solution to this problem has been to provide antibiotics to the animals; however, this solution is not only costly, but it also can result in the generation of antibiotic-resistant strains of bacteria.
Extreme health risks result when humans consume pathogens in contaminated food products such as sprouts, lettuce, meat products, unpasteurized milk and juice, and sewage-contaminated water, for example.
The problem is particularly prevalent in the beef and dairy industry.
Meat can become contaminated during slaughter, and pathogenic organisms can be mixed into large quantities of meat when it is ground.
When humans eat meat, especially ground beef, that has not been cooked sufficiently to kill any pathogens present in the beef, serious and life-threatening infections can result.
This is a difficult problem to solve because contaminated meat often looks and smells perfectly normal.
Furthermore, the number of pathogenic organisms needed to cause disease is extremely small, thus making detection extraordinarily difficult.
These toxins can cause severe distress in the small intestine, often resulting in damage to the intestinal lining and resulting in extreme cases of diarrhea.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

examples 1 and 2

[0028] Several in vitro tests were conducted that demonstrate the ability of particular bacteria to effectively compete with and interfere with the growth of pathogenic bacteria such as E. coli O157:H7 and others.

example 1

[0029] Lyophilized cultures of lactic acid producing and lactate utilizing organisms were selected for their ability to inhibit the growth of pathogens such as E. coli O157:H7, Streptococcus aureus and Salmonella. Combinations of the lactic acid producing and lactate utilizing organisms were further selected for their ability to maximize the inhibition of growth of the various pathogens.

[0030] In order to identify those microorganisms that might be utilized in the method and formulation of the invention, in vitro tests were conducted to identify particularly effective single strains. Seven strains of Propionibacterium and six strains of Lactobacillus were screened for their ability to produce bacteriocins capable of creating zones of inhibition on agar plates that were grown with E. coli O157:H7. The results of those tests are tabulated below.

TABLE 1Inhibitory Activity of Propionibacterium StrainsGrown in Selective MediaP9P42P79P88P93P99PF24PATHOGENGram+B. cereus NoNoNoNoNoNoNoS....

example 2

[0033] Selected strains of Lactobacillus acidophilus and Propionibacterium freudenreichii bacteria were grown in an in vitro comparison with E. coli on rich sem-aerobic media at 38° C. to determine which strains could effectively compete with E. coli growth under in vivo growth conditions. It was found that the LA51 and LA45 strains could substantially out-grow the E. coli.

TABLE 3Growth (Optical Density) of Selected Strains of Bacteria versusE. coli O157:H7 on Rich Semi-Anaerobic Media at 38° C.MINUTESE. coli O157:H7LA45LA51PF2400.20.20.20.2500.30.380.550.3900.450.650.840.351200.600.851.00.362000.801.21.280.382300.851.251.280.393650.901.251.280.504400.901.251.280.58

In Vivo Tests

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria. The treatment method comprises administering a therapeutically effective amount of Lactobacillus acidophilus or one or a combination of a number of other probiotic bacteria to an animal. An alternative treatment method comprises administering a therapeutically effective amount of a lactic acid producing bacterium such as Lactobacillus acidophilus in combination with a lactate utilizing bacterium such as Propionibacterium freudenreichii.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a Divisional Application of U.S. patent application Ser. No.10 / 288,487 filed Nov. 6, 2002. Said application Ser. No. 10 / 288,487 is a Continuation Application of U.S. patent application Ser. No. 10 / 273,141 filed Oct. 18, 2002. Further, said application Ser. No. 10 / 288,487 claims priority to U.S. Provisional Patent Application No. 60 / 319,054 filed Jan. 8, 2002 and Ser. No. 60 / 319,587 filed Oct. 1, 2002, all applications incorporated herein by reference in their entireties.FIELD OF THE INVENTION [0002] The present invention relates to compositions and methods for inhibiting pathogenic growth. More specifically, the invention relates to compositions and methods for inhibiting pathogenic growth through the use of lactic acid producing microorganisms both alone and in combination with lactate utilizing microorganisms. BACKGROUND OF THE INVENTION [0003] Ingestion of pathogens, especially bacterial pathogens, but including v...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A23K1/00A23K1/18A61K35/74A61K35/741A61K35/742A61K35/744A61K35/745A61K35/747A61K45/00
CPCA23K1/009Y10S435/854A61K35/741A61K35/742A61K35/744A61K35/745A61K35/747A23K1/1813Y10S435/822A61K2300/00A23K10/18A23K50/10A61P31/04
Inventor GARNER, BRYAN E.WARE, DOUGLAS R.
Owner NUTRITION PHYSIOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products